US Patent 7390482 Drug for auditory dysfunction

Patent 7390482 was granted and assigned to AnGes MG, Inc. on June, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 16 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Kazuo Oshima0

Ryuichi Morishita0

Takeshi Kubo0

Yasufumi Kaneda0

Edits on 14 Sep, 2023

"Add patent abstract"

Golden AI

edited on 14 Sep, 2023

Edits made to:

Article (+484 characters)

Article

Patent abstract

The present invention provides a pharmaceutical preparation for hearing impairment, which is suitable for gene therapy of hearing impairment, that is, a pharmaceutical preparation for hearing impairment which comprises a virus envelope vector encapsulating a hepatocyte growth factor (HGF) gene or its plasmid as an active ingredient. Particularly, it is suitable as a pharmaceutical preparation for gene therapy for the purpose of prevention and treatment of deafness.

Edits on 21 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 21 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌